Trials / Suspended
SuspendedNCT03217370
Study on Patient Blood Management in Haematological Patients
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The investigators noticed a variable prescription of blood components to haematological patients in the hospital. This study will analyze the prescription and administration of blood components to Haematological patients (pre measurement). Based on these results guidelines on transfusion triggers will be updated and educated to the physicians and new ICT (information and communications technology) implementations will be added to the electronic order for blood components. The investigators hope to see afterwards (post measurement) a more stable prescription and administration of blood components and a more economic use of blood components.
Detailed description
This study is set up as a first step of implementing patient blood management (PBM) in this hospital. PBM is an evidence-based, multidisciplinary approach to optimizing the care of patients who might need transfusion. Not only in pre/per/postoperative setting but also in haematology PBM guidelines can be implemented. Examples are: use of a restrictive haemoglobin trigger for red blood cells (RBC) transfusion, single use policy for the administration of RBC and platelets, administration only for correct indications (including the introduction of an electronic clinical decision support system for ordering blood components), ...
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | education of guidelines | * Guidelines will be updated and education will be given to haematologists in several ways. * ICT implementations: a) last result of haemoglobin and platelet count will be shown on the electronic blood order; b) an electronical clinical decision support system will be implemented to order blood components |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2017-07-14
- Last updated
- 2019-02-18
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03217370. Inclusion in this directory is not an endorsement.